UCB's Global Corporate Website
Welcome to UCB in the United States

Sep

22

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting

Jun

01

Life with MG & What I Wish For Everyone Who is Diagnosed

May

27

My Commitment to the Newly Diagnosed and All People Living with Myasthenia Gravis

May

10

UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis

Feb

25

Recognizing Rare Disease Day Every Day – The Importance of Addressing Unmet Patient Needs

At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

Feb

04

UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results

Dec

10

UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis

Oct

27

Unique Patient-led and Co-authored Analysis of the Experience of Living with Myasthenia Gravis Published in Neurology and Therapy

Jun

03

Elevating the Voice of People with MG

This month in honor of Myasthenia Gravis (MG) Awareness Month, we have an opportunity to elevate the voices and needs of people with MG who remind us each day that our collective efforts can directly impact the everyday lives of MG patients – especially during times when immunocompromised individuals can face even more challenges than usual.

Apr

16

Together Towards Recovery: How a Year of Distance Has Brought Us Closer to the Needs of Patients

With more than 20 years of experience in caring for people living with epilepsy, our goal has always been to know and understand the day-to-day experiences of people living with the disease better than anyone. Over the past year this has been especially true, and the challenges we’ve faced have reinvigorated our commitment to the overall emotional and physical well-being of patients. Read more from UCB’s Head of U.S. Neurology, Mike Davis, about how UCB is finding new ways to better connect with patients and improve their day-to-day experience.